{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T18:04:16Z","timestamp":1788113056654,"version":"build-2803163510"},"update-to":[{"DOI":"10.1002\/14651858.cd001423.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2012,12,12]],"date-time":"2012-12-12T00:00:00Z","timestamp":1355270400000}}],"reference-count":91,"publisher":"Wiley","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd001423.pub3","type":"journal-article","created":{"date-parts":[[2012,12,6]],"date-time":"2012-12-06T18:48:22Z","timestamp":1354819702000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":54,"title":["<i>Serenoa repens<\/i>\n                    for benign prostatic hyperplasia"],"prefix":"10.1002","author":[{"given":"James","family":"Tacklind","sequence":"first","affiliation":[{"name":"Minneapolis Veterans Affairs Medical Center; Center for Chronic Disease Outcomes Research (111-0); One Veterans Drive Minneapolis MN USA 55417"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roderick","family":"MacDonald","sequence":"additional","affiliation":[{"name":"VAMC; General Internal Medicine (111-0); One Veterans Drive Minneapolis MN USA 55417"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Indy","family":"Rutks","sequence":"additional","affiliation":[{"name":"VAMC; Department of Internal Medicine (111-0); One Veterans Drive Minneapolis Minnesota USA 55417"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith U","family":"Stanke","sequence":"additional","affiliation":[{"name":"University of Minnesota; Bio-Medical Library; Minneapolis Minnesota USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy J","family":"Wilt","sequence":"additional","affiliation":[{"name":"VAMC; General Internal Medicine (111-0); One Veterans Drive Minneapolis MN USA 55417"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2012,12,12]]},"reference":[{"issue":"12","key":"10.1002\/14651858.CD001423.pub3-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1001\/jama.2011.1364","article-title":"Effect of increasing doses of Saw palmetto extract on lower urinary tract symptoms","volume":"306","author":"Barry","year":"2011","journal-title":"JAMA"},{"issue":"25","key":"10.1002\/14651858.CD001423.pub3-BIB0002|cit2","first-page":"127","article-title":"Saw palmetto fruit extract for treatment of benign prostatic hyperplasia. Results of a placebo-controlled double-blind study","volume":"141","author":"Bauer HW. Casarosa C. Cosci M. Fratta M. Ble\u03b2mann","year":"1999","journal-title":"MMW Fortschritte der Medizin"},{"issue":"6","key":"10.1002\/14651858.CD001423.pub3-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1056\/NEJMoa053085","article-title":"Saw palmetto for benign prostatic hyperplasia","volume":"354","author":"Bent","year":"2006","journal-title":"The New England Journal of Medicine"},{"key":"10.1002\/14651858.CD001423.pub3-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1177\/039156038305000615","article-title":"Serenoa repens extract and placebo in prostatic benign hyperplasia: clinical results","volume":"50","author":"Boccafoschi","year":"1983","journal-title":"Urologia"},{"issue":"7","key":"10.1002\/14651858.CD001423.pub3-BIB0007|cit5","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/S0011-393X(05)80771-4","article-title":"The extract of Serenoa repens in the treatment of benign prostatic hyperplasia: a multicenter open study","volume":"55","author":"Braeckman","year":"1994","journal-title":"Current Therapeutic Research"},{"key":"10.1002\/14651858.CD001423.pub3-BIB0005|cit6","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1002\/(SICI)1099-1573(199712)11:8<558::AID-PTR158>3.0.CO;2-U","article-title":"Efficacy and safety of the extract of Serenoa repens in the treatment of benign prostatic hyperplasia: therapeutic equivalence between twice and once daily dosage forms","volume":"1","author":"Braeckman","year":"1997","journal-title":"Phytotherapy Research"},{"key":"10.1002\/14651858.CD001423.pub3-BIB0006|cit7","first-page":"247","article-title":"A double-blind, placebo-controlled study of the plant extract Serenoa repens in the treatment of benign hyperplasia of the prostate","volume":"9","author":"Braeckman","year":"1997","journal-title":"European Journal of Clinical Research"},{"issue":"6","key":"10.1002\/14651858.CD001423.pub3-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/j.1464-410X.1990.tb07199.x","article-title":"Treatment of benign prostatic hyperplasia with phytosterols","volume":"66","author":"Carbin","year":"1990","journal-title":"British Journal of Urology"},{"issue":"4","key":"10.1002\/14651858.CD001423.pub3-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/(SICI)1097-0045(199610)29:4<231::AID-PROS4>3.0.CO;2-E","article-title":"Comparison of phytotherapy (Permixon) with finasteride in the treatment of benign prostate hyperplasia: a randomized international study of 1,098 patients","volume":"29","author":"Carraro","year":"1996","journal-title":"The Prostate"},{"key":"10.1002\/14651858.CD001423.pub3-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1365-2125.1984.tb02491.x","article-title":"A double-blind trial of an extract of the plant Serenoa repens in benign prostatic hyperplasia","volume":"18","author":"Champault","year":"1984","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD001423.pub3-BIB0011|cit11","first-page":"15","volume":"4","author":"Cukier","year":"1985","journal-title":"Comptes Rendus de Therapeutique et de Pharmacologie Clinique"},{"key":"10.1002\/14651858.CD001423.pub3-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.eururo.2004.01.015","article-title":"Evaluation of the clinical benefit of Permixon and tamsulosin in severe BPH patients--PERMAL study subset analysis","volume":"45","author":"Debruyne","year":"2004","journal-title":"European Urology"},{"key":"10.1002\/14651858.CD001423.pub3-BIB0013|cit13","first-page":"497","article-title":"Comparison of a phytotherapeutic agent (Permixon\u00ae) with an a-blocker (tamsulosin) in the treatment of benign prostatic hyperplasia: a 1-year randomized international study","volume":"41","author":"Debruyne","year":"2002","journal-title":"Progr\u00e8s en Urologie"},{"key":"10.1002\/14651858.CD001423.pub3-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"291","DOI":"10.2165\/00044011-199509050-00007","article-title":"Placebo-controlled evaluation of the efficacy and tolerability of Permixon\u00ae in benign prostatic hyperplasia after the exclusion of placebo responders","volume":"5","author":"Descotes","year":"1995","journal-title":"Clinical Drug Investigation"},{"key":"10.1002\/14651858.CD001423.pub3-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1177\/039156038305000517","volume":"50","author":"Emili","year":"1983","journal-title":"Urologia"},{"issue":"3","key":"10.1002\/14651858.CD001423.pub3-BIB0016|cit16","first-page":"222","article-title":"Efficacy and safety of a combination of sabal and urtica extract in lower urinary tract symptoms. A randomized, double-blind study versus tamsulosin","volume":"56","author":"Engelmann","year":"2006","journal-title":"Arzneimittel-Forschung"},{"key":"10.1002\/14651858.CD001423.pub3-BIB0017|cit17","first-page":"1775","volume":"37","author":"Gabric","year":"1987","journal-title":"Therapiewoche"},{"issue":"6","key":"10.1002\/14651858.CD001423.pub3-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/S0090-4295(01)01442-X","article-title":"Randomized, double-blind, placebo-controlled trial of saw palmetto in men with lower urinary tract symptoms","volume":"58","author":"Gerber","year":"2001","journal-title":"Urology"},{"key":"10.1002\/14651858.CD001423.pub3-BIB0019|cit19","first-page":"395","article-title":"Tamsulosin with or without Serenoa repens in benign prostatic hyperplasia: the OCOS trial","volume":"12","author":"Gl\u00e9main","year":"2002","journal-title":"Progr\u00e8s en Urologie"},{"key":"10.1002\/14651858.CD001423.pub3-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1007\/s11255-006-9106-5","article-title":"A prospective study of the efficacy of Serenoa repens, tamsulosin, and Serenoa repens plus tamsulosin treatment for patients with benign prostate hyperplasia","volume":"39","author":"Hizli","year":"2007","journal-title":"International Urology and Nephrology"},{"issue":"1-2","key":"10.1002\/14651858.CD001423.pub3-BIB0021|cit21","first-page":"34","volume":"6","author":"L\u00f6belenz","year":"1992","journal-title":"Therapeutikon"},{"issue":"2","key":"10.1002\/14651858.CD001423.pub3-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s00345-005-0501-9","article-title":"Combined extract of sabal palm and nettle in the treatment of patients with lower urinary tract symptoms in the double blind, placebo-controlled trial","volume":"23","author":"Lopatkin","year":"2005","journal-title":"World Journal of Urology"},{"issue":"4","key":"10.1002\/14651858.CD001423.pub3-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1177\/039156038305000414","article-title":"Medical treatment of benign prostatic hyperplasia: efficacy of the extract of Serenoa repens (Permixon\u00ae) compared to that of the extract of Pygeum africanum and a placebo","volume":"50","author":"Mandressi","year":"1983","journal-title":"Urologia"},{"issue":"5","key":"10.1002\/14651858.CD001423.pub3-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/S0022-5347(05)67641-0","article-title":"Effects of a saw palmetto herbal blend in men with symptomatic benign prostatic hyperplasia","volume":"163","author":"Marks","year":"2000","journal-title":"The Journal of Urology"},{"key":"10.1002\/14651858.CD001423.pub3-BIB0025|cit25","first-page":"346","volume":"2","author":"Mattei","year":"1990","journal-title":"TW Urologie Nephrologie"},{"issue":"4","key":"10.1002\/14651858.CD001423.pub3-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1007\/s001310050033","volume":"36","author":"Metzker","year":"1996","journal-title":"Der Urologe B"},{"issue":"1","key":"10.1002\/14651858.CD001423.pub3-BIB0027|cit27","first-page":"26","article-title":"Randomized double-blind controlled clinical trial of Serenoa repens versus placebo in the management of patients with symptomatic Grade I to Grade II benign prostatic hyperplasia (PBH)","volume":"16","author":"Mohanty","year":"1999","journal-title":"Indian Journal of Urology"},{"issue":"5","key":"10.1002\/14651858.CD001423.pub3-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1177\/039156038605300509","volume":"53","author":"Pannunzio","year":"1986","journal-title":"Urologia"},{"key":"10.1002\/14651858.CD001423.pub3-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1023\/A:1015227604041","article-title":"Randomized trial of a combination of natural products (Cernitin, saw palmetto, \u00df-sitosterol, vitamin E) on symptoms of benign prostatic hyperplasia (BPH)","volume":"33","author":"Preuss","year":"2001","journal-title":"International Urology and Nephrology"},{"key":"10.1002\/14651858.CD001423.pub3-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1464-410X.1986.tb05424.x","article-title":"The value of Permixon in benign prostatic hypertrophy","volume":"58","author":"Reece Smith","year":"1986","journal-title":"British Journal of Urology"},{"issue":"2","key":"10.1002\/14651858.CD001423.pub3-BIB0031|cit31","first-page":"61","article-title":"Clinical controlled trial on therapeutical bioequivalence and tolerability of Serenoa repens oral capsules 160 mg or rectal capsules 640 mg","volume":"46","author":"Roveda","year":"1994","journal-title":"Archivio di Medicina Interna"},{"key":"10.1002\/14651858.CD001423.pub3-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.juro.2007.09.032","article-title":"Effect of saw palmetto soft gel capsule on lower urinary tract symptoms associated with benign prostatic hyperplasia: a randomized trial in Shanghai, China","volume":"179","author":"Shi","year":"2008","journal-title":"The Journal of Urology"},{"key":"10.1002\/14651858.CD001423.pub3-BIB0034|cit33","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1046\/j.1464-410X.2000.00776.x","article-title":"Combined sabal and urtica extract compared with finasteride in men with benign prostatic hyperplasia: analysis of prostate volume and therapeutic outcome","volume":"86","author":"S\u00f6keland","year":"2000","journal-title":"British Journal of Urology International"},{"issue":"4","key":"10.1002\/14651858.CD001423.pub3-BIB0033|cit34","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s001200050106","article-title":"Combined sabal and urtica extract compared with finasteride in men with benign prostatic hyperplasia: analysis of prostate volume and therapeutic outcome","volume":"36","author":"S\u00f6keland","year":"1997","journal-title":"Urologe A"},{"key":"10.1002\/14651858.CD001423.pub3-BIB0035|cit35","first-page":"87","article-title":"Treatment of obstructive symptomatology caused by prostatic adenoma with an extract of Serenoa repens. Double-blind clinical study vs placebo","volume":"37","author":"Tasca","year":"1985","journal-title":"Minerva Urologica e Nefrologica"},{"key":"10.1002\/14651858.CD001423.pub3-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1046\/j.1464-410X.2003.04316.x","article-title":"Serenoa repens extract for benign prostate hyperplasia: a randomized controlled trial","volume":"92","author":"Willetts","year":"2003","journal-title":"British Journal of Urology International"},{"issue":"3","key":"10.1002\/14651858.CD001423.pub3-BIB0037|cit37","first-page":"211","article-title":"Symptomatic treatment of benign hypertrophy of the prostate. Comparative study of prazosin and Serenoa repens","volume":"45","author":"Adriazola Semino","year":"1992","journal-title":"Archivos Espanoles de Urologia"},{"key":"10.1002\/14651858.CD001423.pub3-BIB0038|cit38","first-page":"47","article-title":"Efficacy and safety of prostamol-Uno in patients with chronic abacterial prostatitis [article in Russian]","volume":"1","author":"Aliaev","year":"2006","journal-title":"Urologiia"},{"key":"10.1002\/14651858.CD001423.pub3-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/sj.pcan.4500477","article-title":"Early urodynamic effects of the lipido-sterolic extract of Serenoa repens (Permixon\u00ae) in patients with lower urinary tract symptoms due to benign prostatic hyperplasia","volume":"3","author":"Al-Shukri","year":"2000","journal-title":"Prostate Cancer and Prostatic Diseases"},{"issue":"56","key":"10.1002\/14651858.CD001423.pub3-BIB0040|cit40","first-page":"4","volume":"5","author":"Authi\u00e9","year":"1987","journal-title":"Comptes Rendus de Th\u00e9rapeutique et de Pharmacologie Clinique"},{"issue":"2","key":"10.1002\/14651858.CD001423.pub3-BIB0041|cit41","first-page":"122","article-title":"Mepartricin versus Serenoa repens: double-blind study in 20 cases of benign prostate hypertrophy","volume":"6","author":"Comar","year":"1986","journal-title":"Rivista Italiana di Biologia e Medicina"},{"issue":"4","key":"10.1002\/14651858.CD001423.pub3-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1159\/000474863","article-title":"Evidence that Serenoa repens extract displays an antiestrogenic activity in prostatic tissue of benign prostatic hypertrophy patients","volume":"21","author":"Siverio","year":"1992","journal-title":"European Urology"},{"issue":"6","key":"10.1002\/14651858.CD001423.pub3-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/S0090-4295(98)00143-5","article-title":"Saw palmetto (Serenoa repens) in men with lower urinary tract symptoms: effects on urodynamic parameters and voiding symptoms","volume":"51","author":"Gerber","year":"1998","journal-title":"Urology"},{"issue":"2","key":"10.1002\/14651858.CD001423.pub3-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/BF02853174","article-title":"The lipidosterolic extract of Serenoa repens in the treatment of benign prostatic hyperplasia: a comparison of two dosage regimens","volume":"19","author":"Giannakopoulos","year":"2002","journal-title":"Advances in Natural Therapy"},{"issue":"1","key":"10.1002\/14651858.CD001423.pub3-BIB0045|cit45","first-page":"97","article-title":"Comparative effects of alfuzosin versus Serenoa repens in the treatment of symptomatic benign prostatic hyperplasia","volume":"48","author":"Grasso","year":"1995","journal-title":"Archivos Espa\u00f1oles de Urolog\u00eda"},{"issue":"1","key":"10.1002\/14651858.CD001423.pub3-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1177\/039156031007700108","volume":"77","author":"Pavone","year":"2010","journal-title":"Urologia"},{"key":"10.1002\/14651858.CD001423.pub3-BIB0047|cit47","first-page":"73","article-title":"Efficacy of pretreatment with Serenoa repens on bleeding associated with transurethral resection of prostate","volume":"56","author":"Pecoraro","year":"2004","journal-title":"Minerva Urologica e Nefrologica"},{"issue":"Supp 3","key":"10.1002\/14651858.CD001423.pub3-BIB0048|cit48","first-page":"103","volume":"147","author":"Popa","year":"2005","journal-title":"MMW Fortschritte der Medizin"},{"key":"10.1002\/14651858.CD001423.pub3-BIB0049|cit49","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1159\/000322645","article-title":"Long-term efficacy of Serenoa repens treatment in patients with mild and moderate symptomatic benign prostatic hyperplasia","volume":"86","author":"Sinescu","year":"2011","journal-title":"Urologia Internationalis"},{"key":"10.1002\/14651858.CD001423.pub3-BIB0050|cit50","first-page":"S19","article-title":"Long-term efficacy and safety of a combination of sabal and urtica extracts in LUTS - a placebo-controlled, double-blind, multicenter trial","volume":"40(Suppl 1)","author":"Sivkov","year":"2001","journal-title":"Urologe A"},{"issue":"5","key":"10.1002\/14651858.CD001423.pub3-BIB0051|cit51","first-page":"231","article-title":"Efficacy and tolerability of the lipidosterolic extract of Serenoa repens (Permixon\u00ae) in benign prostatic hyperplasia: a double-blind comparison of two dosage regimens","volume":"16","author":"Stepanov","year":"1999","journal-title":"Advances in Therapy"},{"issue":"3","key":"10.1002\/14651858.CD001423.pub3-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1159\/000475388","article-title":"Comparison of finasteride (Proscar\u00ae) and Serenoa repens (Permixon\u00ae) in the inhibition of 5-alpha reductase in healthy male volunteers","volume":"26","author":"Strauch","year":"1994","journal-title":"European Urology"},{"key":"10.1002\/14651858.CD001423.pub3-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0302-2838(03)00368-3","article-title":"BPH and inflammation: pharmacological effects of Permixon on histological and molecular inflammatory markers. Results of a double blind pilot clinical assay","volume":"44","author":"Vela-Navarrete","year":"2003","journal-title":"European Urology"},{"key":"10.1002\/14651858.CD001423.pub3-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/01.ju.0000150533.94952.25","article-title":"Serenoa repens treatment modifies BAX\/BCL-2 index expression and CASPASE-3 activity in prostatic tissue from patients with benign prostatic hyperplasia","volume":"173","author":"Vela-Navarrete","year":"2005","journal-title":"The Journal of Urology"},{"key":"10.1002\/14651858.CD001423.pub3-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0090-4295(02)01838-1","article-title":"Saw palmetto alters nuclear measurements reflecting DNA content in men with symptomatic BPH: evidence for a possible molecular mechanism","volume":"60","author":"Veltri","year":"2002","journal-title":"Urology"},{"key":"10.1002\/14651858.CD001423.pub3-BIB0056|cit56","first-page":"3","article-title":"Results of three-year clinical study of prostamol Uno efficacy and safety in patients with initial symptoms of prostatic adenoma and risk of its progression [Russian]","volume":"6","author":"Vinarov","year":"2010","journal-title":"Urologiia"},{"issue":"1","key":"10.1002\/14651858.CD001423.pub3-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1159\/000474426","article-title":"Enzyme activities in tissue of human benign prostatic hyperplasia after three months' treatment with the Sabal serrulata extract IDS 89 (Strogen) or placebo","volume":"31","author":"Weissser","year":"1997","journal-title":"European Urology"},{"issue":"2","key":"10.1002\/14651858.CD001423.pub3-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1464-410X.1979.tb02846.x","article-title":"The assessment of prostatic obstruction from urodynamic measurements and from residual urine","volume":"51","author":"Abrams","year":"1979","journal-title":"British Journal of Urology"},{"key":"10.1002\/14651858.CD001423.pub3-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S0090-4295(99)00028-X","article-title":"Phytotherapeutic agents in the treatment of lower urinary tract symptoms: a demographic analysis of awareness and use at the University of Chicago","volume":"54","author":"Bales","year":"1999","journal-title":"Urology"},{"issue":"343","key":"10.1002\/14651858.CD001423.pub3-BIB0060|cit60","first-page":"1","article-title":"Complementary and alternative medicine use among adults: United States, 2002","volume":"27","author":"Barnes","year":"2004","journal-title":"Advance data from vital and health statistics of the National Center for Health Statistics"},{"key":"10.1002\/14651858.CD001423.pub3-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S0022-5347(17)49698-4","article-title":"The development of human benign prostatic hyperplasia with age","volume":"132","author":"Berry","year":"1984","journal-title":"The Journal of Urology"},{"issue":"6","key":"10.1002\/14651858.CD001423.pub3-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1111\/j.1464-410X.2003.04735.x","article-title":"Updated meta-analysis of clinical trials of Serenoa repens extract in the treatment of symptomatic benign prostatic hyperplasia","volume":"93","author":"Boyle","year":"2004","journal-title":"British Journal of Urology International"},{"issue":"3","key":"10.1002\/14651858.CD001423.pub3-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1046\/j.1464-410X.1996.00104.x","article-title":"Phytotherapy for the prostate","volume":"78","author":"Buck","year":"1996","journal-title":"British Journal of Urology"},{"key":"10.1002\/14651858.CD001423.pub3-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1097\/01.ju.0000140503.11467.8e","article-title":"Is there a scientific basis for the therapeutic effects of Serenoa repens in benign prostatic hyperplasia? Mechanisms of action","volume":"172","author":"Buck","year":"2004","journal-title":"The Journal of Urology"},{"key":"10.1002\/14651858.CD001423.pub3-BIB0065|cit65","article-title":"Chapter 92\u00a0-\u00a0Benign prostatic hyperplasia: etiology, pathophysiology, epidemiology, and natural history","volume-title":"Campbell-Walsh Urology","volume":"3","author":"Roehrborn","year":"2010"},{"key":"10.1002\/14651858.CD001423.pub3-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0094-0143(21)00964-2","article-title":"Clinical manifestations of benign prostatic hyperplasia and the indications for therapeutic intervention","volume":"17","author":"Christensen","year":"1990","journal-title":"Urology Clinics of North America"},{"key":"10.1002\/14651858.CD001423.pub3-BIB0067|cit67","unstructured":"Higgins JPT Altman DG Stern JAC Chapter 8: Assessing risk of bias in included studies. In:Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011] The Cochrane Collaboration (Available from www.cochrane-handbook.org (accessed 4 March 2011) 2011"},{"key":"10.1002\/14651858.CD001423.pub3-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1016\/j.juro.2008.01.094","article-title":"Phytotherapy for lower urinary tract symptoms secondary to benign prostatic hyperplasia","volume":"179","author":"Dedhia","year":"2008","journal-title":"The Journal of Urology"},{"key":"10.1002\/14651858.CD001423.pub3-BIB0069|cit69","first-page":"143","article-title":"Plant extracts in benign prostatic hyperplasia","volume":"45","author":"Silverio","year":"1993","journal-title":"Minerva Urologica e Nefrologica"},{"key":"10.1002\/14651858.CD001423.pub3-BIB0070|cit70","first-page":"944","article-title":"Indentifying relevant studies for systematic reviews","volume":"312","author":"Dickersin","year":"1994","journal-title":"BMJ"},{"issue":"1","key":"10.1002\/14651858.CD001423.pub3-BIB0071|cit71","first-page":"8","article-title":"Conservative nonhormonal treatment of patients with benign prostatic hyperplasia","volume":"29","author":"Dreikorn","year":"1990","journal-title":"Urologe A"},{"key":"10.1002\/14651858.CD001423.pub3-BIB0072|cit72","unstructured":"Brozek J Oxman A Sch\u00fcnemann H GRADEpro 2008"},{"key":"10.1002\/14651858.CD001423.pub3-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/sj.pcan.4500746","article-title":"Not all brands are created equal: a comparison of selected components of different brands of Serenoa repens extract","volume":"7","author":"Habib","year":"2004","journal-title":"Prostate Cancer and Prostatic Diseases"},{"key":"10.1002\/14651858.CD001423.pub3-BIB0074|cit74","first-page":"39","article-title":"Clinical trials in psychiatry: should protocol deviation censor patient data?","volume":"6","author":"Lavori","year":"1992","journal-title":"Neuropsychopharmacology"},{"key":"10.1002\/14651858.CD001423.pub3-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1056\/NEJM199608223350801","article-title":"The efficacy of terazosin and finasteride, or both in benign prostatic hyperplasia","volume":"335","author":"Lepor","year":"1996","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD001423.pub3-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0090-4295(96)00077-5","article-title":"Phytotherapy in treatment of benign prostatic hyperplasia: a critical review","volume":"48","author":"Lowe FC Ku","year":"1996","journal-title":"Urology"},{"key":"10.1002\/14651858.CD001423.pub3-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.eursup.2006.02.006","article-title":"A critical analysis of Permixon\u2122 in the treatment of lower urinary tract symptoms due to benign prostatic enlargement","volume":"5 suppl","author":"Maccagnano","year":"2006","journal-title":"European Urology"},{"key":"10.1002\/14651858.CD001423.pub3-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1001\/jama.1995.03520320015008","article-title":"Growing use of medicinal botanicals forces assessment by drug regulators","volume":"273","author":"Marwick","year":"1995","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD001423.pub3-BIB0079|cit79","first-page":"1","article-title":"Benign prostatic hyperplasia: diagnosis and treatment. Agency for Health Care Policy and Research","volume":"8","author":"McConnell","year":"1994","journal-title":"Clinical practice guideline. Quick reference guide for clinicians"},{"key":"10.1002\/14651858.CD001423.pub3-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1056\/NEJMoa030656","article-title":"The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia","volume":"349","author":"McConnell","year":"2003","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD001423.pub3-BIB0081|cit81","unstructured":"McGuire E Detrusor response to obstruction NIH Publication No. 87-2881 1987"},{"key":"10.1002\/14651858.CD001423.pub3-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/S0895-4356(01)00351-1","article-title":"Risk factors for clinical benign prostatic hyperplasia in a community-based population of healthy aging men","volume":"54","author":"Meigs","year":"2001","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD001423.pub3-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/S0090-4295(01)01673-9","article-title":"Prevalence of and racial\/ethnic variation in lower urinary tract symptoms and noncancer prostate surgery in US men","volume":"59","author":"Platz","year":"2002","journal-title":"Urology"},{"key":"10.1002\/14651858.CD001423.pub3-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0090-4295(01)01155-4","article-title":"Clinical predictors of spontaneous acute urinary retention in men with LUTS and clinical BPHL a comprehensive analysis of the pooled placebo groups of several large studies","volume":"58","author":"Roehrborn\u00a0CG","year":"2001","journal-title":"Urology"},{"key":"10.1002\/14651858.CD001423.pub3-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.1995.03520290060030","article-title":"Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials","volume":"273","author":"Schulz","year":"1995","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD001423.pub3-BIB0086|cit86","first-page":"45","article-title":"Chapter 2, Benign Prostatic Hyperplasia","volume-title":"Urologic Diseases in America","author":"Wei","year":"2007"},{"key":"10.1002\/14651858.CD001423.pub3-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/1097-0045(20001101)45:3<259::AID-PROS9>3.0.CO;2-G","article-title":"Induction of apoptosis and inhibition of cell proliferation by the lipido-sterolic extract of Serenoa repens (LSESr, Permixon\u00ae) in benign prostatic hyperplasia","volume":"45","author":"Vacherot","year":"2000","journal-title":"The Prostate"},{"key":"10.1002\/14651858.CD001423.pub3-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/(SICI)1097-0045(199605)28:5<300::AID-PROS5>3.0.CO;2-F","article-title":"Effects of the sabal serrulata extract IDS 89 and its subfractions on 5 alpha-reductase activity in human benign prostatic hyperplasia","volume":"28","author":"Weisser","year":"1996","journal-title":"The Prostate"},{"issue":"2. Art. No.: CD","key":"10.1002\/14651858.CD001423.pub3-BIB0089|cit89","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001423.pub2","article-title":"Serenoa repens for benign prostatic hyperplasia","author":"Tacklind","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD001423.pub3-BIB0090|cit90","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001423","article-title":"Serenoa repens for benign prostatic hyperplasia","author":"Wilt","year":"2000","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD001423.pub3-BIB0091|cit91","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001423","article-title":"Serenoa repens for benign prostatic hyperplasia","author":"Wilt","year":"2002","journal-title":"Cochrane Database of Systematic Reviews"}],"updated-by":[{"DOI":"10.1002\/14651858.cd001423.pub4","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2023,6,22]],"date-time":"2023-06-22T00:00:00Z","timestamp":1687392000000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD001423.pub3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,2]],"date-time":"2022-02-02T13:40:21Z","timestamp":1643809221000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD001423.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Urology Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,12,12]]},"references-count":91,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd001423.pub3","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.717969419.793470316","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.717969419.793469714","asserted-by":"object"}]},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12,12]]}}}